Trial · NCT07891403
A Study on the Clinical Efficacy of Fumigation and Washing With Modified Astragalus and Cinnamon Twig Decoction With Five Herbs in the Treatment of Post-Chemotherapy Peripheral Neuropathy
NCT07891403, Phase 2, Completed, Emeishan Hospital of Traditional Chinese Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study on the Clinical Efficacy of Fumigation and Washing With Modified Astragalus and Cinnamon Twig Decoction With Five Herbs in the Treatment of Post-Chemotherapy Peripheral Neuropathy. Trials, record NCT07891403. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891403
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study on the Clinical Efficacy of Fumigation and Washing With Modified Astragalus and Cinnamon Twig Decoction With Five Herbs in the Treatment of Post-Chemotherapy Peripheral Neuropathy
- NCT number
- NCT07891403
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 7 participants, actual
- Lead sponsor
- Emeishan Hospital of Traditional Chinese Medicine
- Conditions
- Post-Chemotherapy Peripheral Neuropathy
- Interventions
- Traditional Chinese Medicine Steam Bath
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient Experience | On days 1, 3, and 5 after fumigation, as well as during the second week and at one month. | Numbness, pain, and abnormal sensations in the hands and feet |
| Primary | CIPN Grading Criteria | On days 1, 3, and 5 after fumigation, as well as during the second week and at one month. | On a scale of 0 to 4: Level 0: Asymptomatic; Level 1: Absence of tendon reflexes or numbness (including a prickling sensation), but with no impact on function Level 2: Sensory loss or numbness (including a prickling sensation), affecting function but not daily living activities Level 3: Sensory loss or numbness (including a prickling sensation), affecting daily living activities Level 4: Long-term sensory loss, affecting function |
| Primary | Quality of Life Questionnaire QLQ-C30 | On days 1, 3, and 5 after fumigation, as well as during the second week and at one month. | (Original Total Score - Number of Questions) / (Number of Questions × 3) × 100，0-19 points: Level 0 (asymptomatic); 20-39 points: Level 1 (mild); 40-69 points: Level 2 (moderate);70-100 points: Levels 3-4 (severe) |
| Primary | Hospital Anxiety and Depression Scale | On days 1, 3, and 5 after fumigation, as well as during the second week and at one month. | Add up the scores for the 7 questions：0-7 points Normal range, 8-10 points Mild, 11-14 points Moderate, 15-21 points Severe |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891403
GET https://conductscience.org/api/trials/v1/NCT07891403/registered